Authors: HATTON, RANDY C. (AUTHOR)
Superior Title: Scientific American. Mar2024, Vol. 330 Issue 3, p64-69. 6p. 2 Color Photographs, 1 Diagram.
Subject Terms: FREEDOM of Information Act (U.S.), DRUG approval
Authors: Collins, Jennifer P.1 JCollins3@cdc.gov, Crowe, Samuel J.1, Ortega-Sanchez, Ismael R.2, Bahta, Lynn3, Campos-Outcalt, Doug4, Loehr, Jamie5, Morgan, Rebecca L.6, Poehling, Katherine A.7, McNamara, Lucy A.1
Superior Title: MMWR: Morbidity & Mortality Weekly Report. 4/18/2024, Vol. 73 Issue 15, p345-350. 6p.
Subject Terms: *MENINGOCOCCAL vaccines, *DRUG approval, *COMPLEMENT deficiency (Immunology), *ASPLENIA, *IMMUNIZATION
Authors: Althunian, Turki A.1,2 (AUTHOR) tathunian@sfda.gov.sa, Alzenaidy, Bader R.3 (AUTHOR), Alroba, Raseel A.1 (AUTHOR), Almadani, Ohoud A.1 (AUTHOR), Alqahtani, Fahad A.3 (AUTHOR), Binajlan, Albatool A.3 (AUTHOR), Almousa, Amal I.3 (AUTHOR), Alamr, Deema K.3 (AUTHOR), Al-Mofada, Malak S.3 (AUTHOR), Alsaqer, Nora Y.3 (AUTHOR), Alarfaj, Hessa A.3 (AUTHOR), Bahlewa, Abdulmohsen A.3 (AUTHOR), Alharbi, Mohammed A.3 (AUTHOR), Alhomaidan, Ali M.4 (AUTHOR), Alsuwyeh, Abdulaziz A.3 (AUTHOR), Alsaleh, Abdulmohsen A.3 (AUTHOR)
Superior Title: BMC Medical Research Methodology. 4/5/2024, Vol. 24 Issue 1, p1-10. 10p.
Subject Terms: *DRUG approval, *GENERIC drugs, *CARDIOVASCULAR agents, *BIOPHARMACEUTICS, *SAMPLE size (Statistics)
Geographic Terms: SAUDI Arabia
Authors: Lobinska, Gabriela1 (AUTHOR), Tretyachenko, Vyacheslav1 (AUTHOR), Dahan, Orna1 (AUTHOR), Nowak, Martin A.2 (AUTHOR) martin_nowak@harvard.edu, Pilpel, Yitzhak1 (AUTHOR) martin_nowak@harvard.edu
Superior Title: PLoS Biology. 3/15/2024, Vol. 22 Issue 3, p1-5. 5p.
Subject Terms: *DRUG approval, *MEDICATION safety
Alternate Title:
Incorporación de los medicamentos huérfanos a la listas de medicamentos esenciales de la OMS.
Intégration de médicaments orphelins dans les listes des médicaments essentiels de l'OMS.
Включение лекарственных средств для лечения редких болезней в перечень ВОЗ основных лекарственных средств.
Authors: Costa, Enrico1, Moja, Lorenzo2 mojal@who.int, Wirtz, Veronika J.3, van den Ham, Hendrika A.1, Huttner, Benedikt2, Magrini, Nicola4, Leufkens, Hubert G. M.1
Superior Title: Bulletin of the World Health Organization. Jan2024, Vol. 102 Issue 1, p22-31. 10p.
Subject Terms: *DRUG approval, *COMMUNICABLE diseases, *ESSENTIAL drugs, *PROFESSIONAL licenses, *ORPHAN drugs, *COMPARATIVE studies, *DESCRIPTIVE statistics, *RESEARCH funding, *PHARMACY information services, *TUMORS, *RARE diseases, *CHILDREN
Company/Entity: WORLD Health Organization , EUROPEAN Medicines Agency , UNITED States. Food & Drug Administration
Authors: Song, Jae Geun1 (AUTHOR), Baral, Kshitis Chandra1 (AUTHOR), Kim, Gyu-Lin1 (AUTHOR), Park, Ji-Won1 (AUTHOR), Seo, Soo-Hwa1 (AUTHOR), Kim, Da-Hyun1 (AUTHOR), Jung, Dong Hoon1 (AUTHOR), Ifekpolugo, Nonye Linda1 (AUTHOR), Han, Hyo-Kyung1 (AUTHOR) hkhan@dongguk.edu
Superior Title: Drug Delivery. Dec2023, Vol. 30 Issue 1, p1-20. 20p.
Subject Terms: *PROTEIN analysis, *DRUG approval, *LIQUID chromatography-mass spectrometry, *QUANTITATIVE research
Authors: Swaminathan, Arjun1, A. E., Vijayakumar1 aevijay1985@gmail.com, P., Nikhithaa1
Superior Title: Journal of Family Medicine & Primary Care. Oct2023, Vol. 12 Issue 10, p2223-2229. 7p.
Subject Terms: *DRUG approval, *DRUG accessibility, *MONOCLONAL antibodies, *SMALL molecules
Company/Entity: UNITED States. Food & Drug Administration
Authors: Krupka, Michael1
Superior Title: Vanderbilt Law Review. Apr2024, Vol. 77 Issue 3, p937-997. 61p.
Subject Terms: EXHAUSTION of administrative remedies, DRUG approval, PETITIONS, PUBLIC health, LEGISLATIVE amendments
Authors: SIMON, DAVID A.1
Superior Title: Wisconsin Law Review. 2024, Vol. 2024 Issue 3, p1079-1147. 69p.
Subject Terms: *GENERIC drug manufacturing, *LEGAL liability, *PHARMACEUTICAL industry, OFF-label use (Drugs), DRUG approval, MEDICAL equipment, GENERIC drugs
Company/Entity: UNITED States. Food & Drug Administration
Authors: Myshko, Denise
Superior Title: Formulary Watch. 9/22/2023, p1-4. 4p.
Subject Terms: THERAPEUTIC use of antineoplastic agents, DRUG approval, MYELOFIBROSIS, INVESTIGATIONAL drugs, B cell lymphoma, DRUG development, TUMORS, MULTIPLE myeloma, BREAST tumors
Alternate Title: ABSC CONGRÈS 2023 PRÉSENTATIONS ÉCLAIR.
Superior Title: Journal of the Canadian Health Libraries Association (JCHLA). Aug2023, Vol. 44 Issue 2, p64-69. 6p.
Subject Terms: *MEDICAL library associations, *DRUG approval, *COVID-19, *INFORMATION services, *PROFESSIONAL employee training, *SOCIAL justice, *CONFERENCES & conventions, *HEALTH literacy, *CRITICAL care medicine, *SUSTAINABLE development
Geographic Terms: NOVA Scotia
Authors: Harrison, Todd taharrison@venable.com
Superior Title: Nutraceuticals World. Apr/May2024, Vol. 27 Issue 3, p22-25. 4p.
Subject Terms: *DIETARY supplements industry, *FOOD labeling, *CURRENT good manufacturing practices, DRUG approval laws, TIME measurements
Company/Entity: UNITED States. Food & Drug Administration
Superior Title: Congressional Digest. Mar2024, Vol. 103 Issue 3, p27-27. 1p.
Subject Terms: *DRUG approval, *DRUG prices, *BIPARTISANSHIP, *PHARMACEUTICAL industry
Geographic Terms: UNITED States
Company/Entity: UNITED States. Food & Drug Administration
Authors: Kapczynski, Amy1 amy.kapczynski@yale.edu
Superior Title: Journal of Health Politics, Policy & Law. Apr2023, Vol. 48 Issue 2, p215-239. 25p.
Subject Terms: *ECONOMICS, *HEALTH care reform, *PHARMACEUTICAL industry, *POWER (Social sciences), DRUG approval, DRUG efficacy, HEALTH policy, PRACTICAL politics, VACCINE development, DRUG development, PATIENT safety
Geographic Terms: UNITED States
Company/Entity: UNITED States. Food & Drug Administration
Superior Title: Formulary Watch. 12/14/2023, p1-3. 3p.
Subject Terms: *PHARMACEUTICAL industry, THERAPEUTIC use of antineoplastic agents, DRUG approval, SMALL cell carcinoma, ANTINEOPLASTIC agents, DRUGS, T cells, PROGRESSION-free survival, IMMUNOTHERAPY, PHARMACODYNAMICS
Company/Entity: UNITED States. Food & Drug Administration
Superior Title: Formulary Watch. 11/16/2023, p1-3. 3p.
Subject Terms: *MERGERS & acquisitions, *MEDICARE, DRUG approval, LUNG cancer, PROTEIN-tyrosine kinase inhibitors, GENES
Company/Entity: UNITED States. Food & Drug Administration
Authors: Spivey, Chris
Superior Title: Pharmaceutical Technology Europe. Feb2024, Vol. 36 Issue 2, p11-14. 4p.
Subject Terms: *INSTITUTIONAL cooperation, *INVESTMENTS, *INVENTORY shortages, *HEALTH services administration, *SOCIAL support, *GOVERNMENT regulation, *NEGOTIATION, *MANUFACTURING industries, *DRUG packaging, *ORGANIZATIONAL goals, *BUSINESS networks, *HEALTH insurance reimbursement, *SUPPLY chains, *PATENTS, *INTELLECTUAL property, *INTERPROFESSIONAL relations, *QUALITY assurance, *DRUG labeling, *COMMUNICATION, *PHARMACEUTICAL industry, *COVID-19 pandemic, *PUBLIC opinion, DRUG approval, VACCINES, CELLULAR therapy, MEDICAL supplies, DRUGS, GENE therapy, PSYCHOLOGICAL resilience, MEDICAL research
Company/Entity: EUROPEAN Medicines Agency , UNITED States. Food & Drug Administration
Authors: Nachlis, Herschel1 (AUTHOR) herschel.s.nachlis@dartmouth.edu, Thomson, Kyle2 (AUTHOR) kylethomson2@gmail.com
Superior Title: Journal of Health Politics, Policy & Law. Feb2024, Vol. 49 Issue 1, p73-98. 26p.
Subject Terms: *COVID-19 vaccines, *GOVERNMENT regulation, *ECONOMICS, *DECISION making, *INTERPROFESSIONAL relations, *PHARMACEUTICAL industry, *COVID-19 pandemic, DRUG approval, DRUG efficacy, HOSPITAL emergency services, PRACTICAL politics, DRUG design, PATIENT safety
Company/Entity: UNITED States. Food & Drug Administration
Authors: Alom, Md. Murshid1 (AUTHOR), Faruqe, Md Omar2 (AUTHOR), Molla, Md. Khademul Islam2 (AUTHOR), Rahman, Md Motiur1 (AUTHOR)
Superior Title: BioMed Research International. 6/15/2023, p1-26. 26p.
Subject Terms: *BIOMARKERS, *DRUG approval, *BIOCHEMISTRY, *PHENOMENOLOGICAL biology, *BIOINFORMATICS, *GENE expression, *GENES, *SURVIVAL analysis (Biometry), *RESEARCH funding, *COMPUTER-assisted molecular modeling, *MOLECULAR structure
Company/Entity: UNITED States. Food & Drug Administration
Authors: Beretta, Giorgia1, Marelli, Luca2,3 luca.marelli@unimi.it
Superior Title: Bioethics. Jun2023, Vol. 37 Issue 5, p498-507. 10p. 1 Diagram.
Subject Terms: *DRUG approval, *COVID-19, *ETHICS, *VACCINES, *SARS-CoV-2, *COVID-19 vaccines, *EPIDEMICS, *BIOTECHNOLOGY
Company/Entity: EUROPEAN Union